Jyotirmay Biswas Selected Research

Gold

3/2021	Further evidence of the association of latent Mycobacterium tuberculosis in Eales' disease.
2/2015	A case of subretinal tubercular abscess presenting as disc edema.
6/2012	Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jyotirmay Biswas Research Topics

Disease

33	Uveitis 02/2024 - 09/2008
27	Neoplasms (Cancer) 01/2016 - 07/2003
16	Retinoblastoma (Glioblastoma, Retinal) 09/2018 - 03/2004
14	Scleritis (Episcleritis) 09/2023 - 02/2006
14	Inflammation (Inflammations) 09/2023 - 03/2002
10	Tuberculosis (Tuberculoses) 09/2021 - 01/2002
10	Melanoma (Melanoma, Malignant) 03/2021 - 08/2003
9	Eales disease 10/2022 - 09/2002
8	Cataract (Cataracts) 01/2024 - 10/2004
8	Granuloma 07/2023 - 10/2010
8	Retinal Detachment (Retinal Detachments) 01/2022 - 05/2002
8	Neoplasm Metastasis (Metastasis) 01/2016 - 08/2003
7	Intermediate Uveitis (Chronic Cyclitis) 02/2024 - 06/2003
7	Infections 06/2023 - 06/2005
7	Retinitis 08/2021 - 12/2003
7	Uveal melanoma 01/2016 - 08/2003
6	Anterior Uveitis 01/2024 - 06/2003
6	Abscess 01/2023 - 02/2015
5	Vitreous Hemorrhage 04/2022 - 05/2002
5	Acquired Immunodeficiency Syndrome (AIDS) 09/2020 - 06/2002
4	Acute Retinal Necrosis Syndrome 01/2024 - 06/2014
4	Macular Edema 01/2024 - 01/2018
4	Syphilis 02/2022 - 01/2015
4	Endophthalmitis (Ophthalmia) 01/2022 - 01/2010
4	Retinal Vasculitis 09/2021 - 07/2003
4	Sarcoidosis (Schaumann Disease) 12/2020 - 03/2012
4	Wounds and Injuries (Trauma) 05/2020 - 11/2013
4	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 01/2019 - 01/2004
3	Posterior Uveitis 01/2024 - 04/2013
3	Choroiditis 07/2023 - 12/2016
3	Glaucoma 12/2022 - 01/2016
3	Ischemia 09/2021 - 05/2002
3	Panuveitis 09/2020 - 05/2017
3	Sympathetic Ophthalmia (Sympathetic Uveitis) 05/2020 - 03/2003
3	Necrosis 09/2019 - 12/2002
3	Carcinoma (Carcinomatosis) 04/2005 - 07/2003
2	Macular Degeneration (Age-Related Maculopathy) 07/2023 - 01/2019
2	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2023 - 09/2002
2	Multifocal Choroiditis 07/2023 - 01/2009
2	White Dot Syndromes 07/2023 - 07/2007
2	Vasculitis (Vasculitides) 10/2022 - 07/2011
2	COVID-19 03/2022 - 01/2022
2	Rheumatoid Arthritis 01/2022 - 05/2007
2	Pain (Aches) 11/2021 - 09/2017
2	Lymphoma (Lymphomas) 07/2021 - 01/2013
2	Atrophy 07/2021 - 04/2021
2	Papilledema 09/2020 - 01/2018
2	Hemorrhage 09/2020 - 08/2010
2	Cysts 12/2019 - 10/2012
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2019 - 04/2017

Drug/Important Bio-Agent (IBA)

26	Retinaldehyde (Retinal)IBA 02/2024 - 05/2002
23	SteroidsIBA 04/2023 - 03/2003
15	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 05/2002
13	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2003
9	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2009
6	Monoclonal AntibodiesIBA 04/2005 - 08/2003
6	Histocompatibility Antigens Class IIBA 04/2005 - 08/2003
5	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 02/2006
5	Dexamethasone (Maxidex)FDA LinkGeneric 05/2019 - 10/2015
5	Histocompatibility Antigens Class IIIBA 03/2004 - 08/2003
4	Fluorescein (Funduscein)FDA LinkGeneric 07/2023 - 10/2010
4	Adalimumab (Humira)FDA Link 02/2021 - 10/2018
4	AcidsIBA 01/2020 - 08/2015
4	HLA Antigens (Human Leukocyte Antigens)IBA 04/2017 - 09/2003
4	Epithelial Cell Adhesion MoleculeIBA 01/2015 - 12/2004
4	ParaffinIBA 10/2009 - 01/2002
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2023 - 03/2022
3	tofacitinibIBA 09/2023 - 09/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 08/2010
3	GoldIBA 03/2021 - 06/2012
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 04/2009
3	RNA (Ribonucleic Acid)IBA 11/2018 - 09/2008
3	Acyclovir (Aciclovir)FDA LinkGeneric 02/2018 - 12/2003
3	MicroRNAs (MicroRNA)IBA 01/2016 - 10/2009
3	AntibodiesIBA 09/2008 - 05/2007
3	tapasinIBA 03/2004 - 09/2003
3	CalnexinIBA 03/2004 - 09/2003
3	Histocompatibility Antigens (Histocompatibility Antigen)IBA 03/2004 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 07/2023 - 04/2010
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 07/2023 - 04/2013
2	ReaginsIBA 02/2022 - 01/2015
2	CytokinesIBA 01/2022 - 01/2015
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019 - 08/2009
2	Ganciclovir (Cytovene)FDA LinkGeneric 02/2018 - 01/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018 - 09/2008
2	Tuberculin (PPD)IBA 01/2018 - 06/2012
2	Silicone OilsIBA 12/2017 - 09/2008

Therapy/Procedure

34	Therapeutics 02/2024 - 03/2003
7	Highly Active Antiretroviral Therapy (HAART) 09/2020 - 06/2002
7	Vitrectomy 12/2018 - 10/2009
5	Drug Therapy (Chemotherapy) 12/2016 - 12/2003
4	Immunomodulation 01/2023 - 11/2018
4	Vitreoretinal Surgery 05/2020 - 05/2002
4	Lasers (Laser) 01/2018 - 05/2002
3	Intravitreal Injections 05/2019 - 12/2017
3	Light Coagulation 01/2018 - 05/2002
2	Injections 01/2024 - 10/2018
2	Slit Lamp 04/2022 - 10/2020
2	Biological Therapy 01/2022 - 01/2020
2	Radiotherapy 03/2021 - 12/2003